@misc{indiciae81013be740e3,
  title = {Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma},
  author = {Mondello, P. and Tadros, S. and Teater, M. and Fontan, L. and Chang, A. and Jain, N. and Singh, S. and Ma, M. C. J. and Yang, H. and Toska, E. and Alig, S. and Durant, M. and de Stanchina, E. and Mottok, A. and Nastoupil, L. and Neelapu, S. and Weigert, O. and Inghirami, G. and Baselga, J. and Dhogan, A. and Younes, A. and Yee, C. and Scheinberg, D. and Melnick, A. and Green, M.},
  year = {2019},
  doi = {10.1101/531954},
  url = {https://www.biorxiv.org/content/10.1101/531954v1},
  note = {Source identifier: 10.1101/531954}
}